ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,915Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 1155

$680K Total Retail Price of All Prescriptions

Rank: 9 out of 1155

598 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 598 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

20% of this provider’s 598 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 12,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 570 485 1 5
AMLODIPINE BESYLATE 529 500 2 6
HYDROCODONE-ACETAMINOPHEN 475 449 S3 3 4
FUROSEMIDE 463 430 4 8
LEVOTHYROXINE SODIUM 457 397 5 2
POTASSIUM CHLORIDE 389 343 6 16
LISINOPRIL 376 353 7 1
METOPROLOL TARTRATE 370 322 8 14
CITALOPRAM HBR 330 287 9 19
LOVASTATIN 285 262 10 13
METFORMIN HCL 250 242 11 7
WARFARIN SODIUM 210 201 12 11
HYDROCHLOROTHIAZIDE 205 203 13 9
DICLOFENAC SODIUM 180 160 14 93
METOPROLOL SUCCINATE 178 159 15 17
CEPHALEXIN 172 154 16 111
CIPROFLOXACIN HCL 167 150 17 72
TAMSULOSIN HCL 165 161 18 27
TRAMADOL HCL 164 117 19 32
ATORVASTATIN CALCIUM 160 151 20 12
DONEPEZIL HCL 158 158 21 41
SIMVASTATIN 156 156 22 3
ATENOLOL 150 143 23 10
ZOLPIDEM TARTRATE 143 140 24 21
TRAZODONE HCL 140 105 25 22
CARVEDILOL 135 130 26 28
DIGOXIN 135 135 26 54
POLYETHYLENE GLYCOL 3350 131 117 28 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 100 29 26
CLOPIDOGREL 120 110 30 70
NAMENDA 120 120 30 67
PREDNISONE 116 96 32 40
LOSARTAN POTASSIUM 109 109 33 18
NAPROXEN 103 100 34 81
QUETIAPINE FUMARATE 101 87 35 77
IBUPROFEN 99 84 36 63
AZITHROMYCIN 85 81 37 57
GABAPENTIN 82 80 38 15
PROAIR HFA 82 73 38 31
ALLOPURINOL 81 80 40 29
RISPERIDONE 77 60 41 73
PRAVASTATIN SODIUM 77 77 41 20
CYCLOBENZAPRINE HCL 75 49 R 43 38
GLYBURIDE-METFORMIN HCL 74 71 R 44 199
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 69 44 113
LEVOFLOXACIN 73 65 46 159
OXYCODONE-ACETAMINOPHEN 66 59 S2 47 45
SPIRIVA 65 65 48 49
TERAZOSIN HCL 64 64 49 107
GLYBURIDE 64 60 R 49 75
GEMFIBROZIL 63 57 51 78
ESCITALOPRAM OXALATE 61 49 52 95
ADVAIR DISKUS 56 48 53 35
NYSTATIN 54 39 54 151
PLAVIX 54 49 54 115
OXYBUTYNIN CHLORIDE 53 32 56 71
VENTOLIN HFA 53 40 56 84
SERTRALINE HCL 52 48 58 24
CELEBREX 52 52 58 132
FLUTICASONE PROPIONATE 51 51 60 37
GLIPIZIDE 50 42 61 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.